LITTLETON, Colo., Oct. 02, 2023 (GLOBE NEWSWIRE) — Vivos Therapeutics, Inc. (the “Firm” or “Vivos”) (NASDAQ:VVOS)a number one medical system and know-how firm specializing within the improvement and commercialization of extremely efficient, proprietary oral home equipment for the therapy of breathing-related sleep problems, at this time introduced that world famend creator James Nestor will headline a multidisciplinary checklist of distinguished audio system on the Firm’s Fifth Annual Respiratory Wellness Convention. This yr’s convention will probably be held October 26-28 in Puerto Vallarta, Mexico.
In his New York Instances best-selling guide, BreathMr. Nestor chronicles his personal fascinating journey of discovery and therapeutic. In line with mrjamesnestor.com, “Fashionable analysis in pulmonology, psychology, biochemistry, and human physiology is exhibiting us that making even slight changes to the best way we inhale and exhale may help jump-start athletic efficiency, rejuvenate inside organs, halt loud night breathing, allergy symptoms, bronchial asthma, and a few autoimmune illness, and even straighten spines. None of this must be doable, and but it’s.”
That message is on the core of Vivos’ big selection of product choices and resonates with each one of many over 1,800 Vivos-trained dentists in the US and Canada. Which is sensible, since Vivos owns and presents the know-how that Mr. Nestor used efficiently throughout his personal private therapy.
Becoming a member of Mr. Nestor as keynote audio system are nationally famend and best-selling authors Joe Sweeney and David McCarty, MD, a board licensed sleep specialist. Different convention audio system and presenters embrace specialists from all kinds of dental and medical disciplines akin to cardiology, pediatrics, specialty chiropractic, laser remedy, airway dentistry, and apply administration. Attendees will be taught and expertise firsthand from each printed scientific papers and particular person instances how the very newest ideas and therapy breakthroughs from Vivos are yielding considerably improved medical ends in a shorter therapy time.
Kirk Huntsman, Chairman and CEO of Vivos, acknowledged, “We’re thrilled to host our Fifth Annual Respiratory Wellness Convention. This yr’s convention will probably be primarily user-focused, offering Vivos-trained docs with our newest updates and sources to assist them higher serve their sufferers. This contains the a number of new companies, merchandise and applied sciences we now have not too long ago added to our choices, together with new superior coaching choices which might be merely unavailable anyplace else. For us, the best satisfaction comes after the convention, as our docs return and begin implementing what they discovered with sufferers.”
About Vivos Therapeutics, Inc.
Vivos Therapeutics, Inc. (NASDAQ: VVOS) is a medical know-how firm targeted on growing and commercializing modern diagnostic and therapy strategies for sufferers affected by respiration and sleep points arising from sure dentofacial abnormalities akin to mild-to-moderate obstructive sleep apnea (OSA) and loud night breathing in adults. The Vivos Methodology represents the primary clinically efficient nonsurgical, noninvasive, nonpharmaceutical and cost-effective answer for treating delicate to average OSA. It has confirmed efficient in roughly 40,000 sufferers handled worldwide by greater than 1,800 educated dentists.
The Vivos Methodology contains the Vivos Full Airway Repositioning and/or Enlargement (CARE) equipment remedy and related protocols that alter the scale, form and place of the gentle tissues that comprise a affected person’s higher airway and/or palate. The Vivos Methodology opens airway house and should considerably cut back signs and circumstances related to mild-to-moderate OSA, akin to reducing Apnea Hypopnea Index scores. Vivos additionally markets and distributes SleepImage diagnostic know-how beneath its VivoScore program for house sleep testing in adults and kids. The Vivos Built-in Observe (VIP) program presents dentists coaching and different value-added companies in reference to utilizing The Vivos Methodology.
For extra data, go to www.vivos.com.
Cautionary Observe Concerning Ahead-Trying Statements
This press launch, the convention referred to herein, and statements of the Firm’s administration made in connection therewith comprise “forward-looking statements” (as outlined in Part 27A of the Securities Act of 1933, as amended, and Part 21E of the Securities Trade Act of 1934, as amended) regarding future occasions, notably with respect to the general public providing described herein. Phrases akin to “might”, “ought to”, “expects”, “tasks,” “intends”, “plans”, “believes”, “anticipates”, “hopes”, “estimates”, “purpose” and variations of such phrases and comparable expressions are supposed to establish forward-looking statements. These statements contain important recognized and unknown dangers and are based mostly upon a number of assumptions and estimates, that are inherently topic to important uncertainties and contingencies, a lot of that are past Vivos’ management. Precise outcomes (together with, with out limitation, any anticipated advantages to the Firm of the Respiratory Wellness Convention as described herein) might differ materially from these expressed or implied by such forward-looking statements. Components that would trigger precise outcomes to vary materially embrace, however should not restricted to: (i) the chance that Vivos could also be unable to implement income, gross sales and advertising and marketing methods that enhance revenues, (ii) dangers related to regulatory scrutiny of and antagonistic publicity within the sleep apnea therapy sector; (iii) the chance that Vivos could also be unable to safe extra financings on cheap phrases when wanted, if in any respect and (iv) different threat elements described in Vivos’ filings with the Securities and Trade Fee (“SEC”). Vivos’ filings might be obtained freed from cost on the SEC’s web site at www.sec.gov. Besides to the extent required by legislation, Vivos expressly disclaims any obligations or enterprise to launch publicly any updates or revisions to any forward-looking statements contained herein to replicate any change in Vivos’ expectations with respect thereto or any change in occasions, circumstances, or circumstances on which any assertion is predicated.
Vivos Investor Relations Contact:
Julie Gannon
Investor Relations Officer
720-442-8113
jgannon@vivoslife.com